EU-funded project works to better understand human and parasite interactions

Whipworms are parasitic roundworms that live preferentially in the human cecum, the blind pouch at the beginning of the large intestine. They tunnel through epithelial cells and cause inflammation, potentially resulting in trichuriasis, an infection similar to colitis.

Despite extensive research, the role of whipworm interactions with host epithelial and immune cells in triggering parasite expulsion remains unclear. This has hindered the development of anti-parasite therapies.

The goal of the EU-funded GUTWORM project was to investigate and understand the interaction between whipworms and host cells. To achieve this, project researchers used T. muris, a mouse model, to replicate whipworm infection in humans.

The GUTWORM project had various aims. First, the team set out to identify new parasite and host genes that could interplay and modulate immunological outcomes.

It also characterized the role of host genes in whipworm infection and immunity. Here, novel and known candidate genetic mutations conferring susceptibility to colitis were targeted. GUTWORM researchers tested mice with particular mutations to evaluate the influence of these on anti-parasite immunity and expulsion.

Finally, after identifying key genes regulating the immune response to whipworms, the team explored the precise mechanisms of these genes to help them understand their effect on the parasite.

The GUTWORM project has generated a wealth of fundamental data on host-whipworm interactions. Ultimately, this will provide tools for future efforts to control these parasites, identifying potential new therapeutic targets for diseases that cause suffering in people living in tropical and sub-tropical regions.

The resulting knowledge of the parasite-immunological interplay could also help scientists understand other intestinal inflammatory diseases such as ulcerative colitis.

Source: European Commission

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose